Structural
LAA Closure Learning Series
LAA Exclusion - Indications, Devices and Clinical Data
Advertisement
Episodes
Can We Do Better? Next Generation LAAO Devices
12 min.
AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?
7 min.
Ultimate Stroke Prevention: LAAO in Association With Medical Therapy/Other Procedures
6 min.
LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?
6 min.
No: The Transcatheter Devices Have Much Better Results
9 min.
Yes: Based on LAAOS III, All LAA Should Be Ligated at the Time of Concurrent Heart Surgery
4 min.
LAAO: Follow-up Postprocedural Imaging: CT Should Be the New Gold Standard
10 min.
US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation
14 min.
Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device
11 min.
Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials
8 min.
First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study
11 min.
Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?
12 min.
This Is the Way I Do Watchman FLX: Please Disagree With Every Single Step!
42 min.
One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial
19 min.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results
20 min.
Present Devices to Future Solutions
19 min.
The Next Generation of LAAC Device and Tailored Therapy
22 min.
LAAC Safety: Current Data and Practices
14 min.
Position 2: Hey… What About Creating an Atrial Shunt for Heart Failure
12 min.
Novel LAAO Devices in the Pipeline
10 min.
Left Atrial Appendage Closure with a Mapping Decapolar Catheter Utilizing a Jugular Vein Approach After Failed Femoral Vein Attempt
11 min.
Innovative Use of PDA Amplatzer Devices for Occlusion of Small-Bore LA-LAA Communications Following Incomplete Surgical LAA Ligation
11 min.
Con: Do We Have the Right Definitions for LAAO Success?
14 min.
Pro: Go Big or Go Home: If in Doubt, You Should Oversize Your LAAO Device
7 min.
The Olde Standards (Watchman Flex and Amulet)
9 min.
Case 2: Discordance Imaging: Sizing and Device Selection With Standard Imaging Resources (TEE or CTA)
13 min.
Case 3: My Clinical and Anatomical Inclusion/Exclusion Criteria for Selecting Patients for ICE-Guided LAAO
16 min.
New Kids on the Block! (LAmbre, Omega, Conformal, Laminar, …)
13 min.
Developing a Successful LAAO Program – ‘Master Class’ Tips and Tricks
9 min.
The Future of LAAO? Pre and Intraprocedural CT Guidance
9 min.
LAAO Technology Overview and Basic Procedural Do’s and Don’ts (Case Examples)
14 min.
LAAC Device Surveillance: Significance of Peri-Device Leaks and Device-Related Thrombus
8 min.
Amulet
5 min.
Watchman Flex
3 min.
LAAO vs DOACs: Ongoing Trials and My Prediction
8 min.
Current FDA-Approved Devices: How to Select; Lesion-Specific Differences
6 min.
LAA Closure Clinical Trial & Registry Update 2022
4 min.
Ongoing Clinical Trials and the Future of LAAC
5 min.